<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38755688</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).</ArticleTitle><Pagination><StartPage>326</StartPage><MedlinePgn>326</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">326</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-024-08156-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-acute sequelae of SARS-CoV-2 infection (PASC) symptoms have broad impact, and may affect individuals regardless of COVID-19 severity, socioeconomic status, race, ethnicity, or age. A prominent PASC symptom is cognitive dysfunction, colloquially referred to as "brain fog" and characterized by declines in short-term memory, attention, and concentration. Cognitive dysfunction can severely impair quality of life by impairing daily functional skills and preventing timely return to work.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">RECOVER-NEURO is a prospective, multi-center, multi-arm, phase 2, randomized, active-comparator design investigating 3 interventions: (1) BrainHQ is an interactive, online cognitive training program; (2) PASC-Cognitive Recovery is a cognitive rehabilitation program specifically designed to target frequently reported challenges among individuals with brain fog; (3) transcranial direct current stimulation (tDCS) is a noninvasive form of mild electrical brain stimulation. The interventions will be combined to establish 5 arms: (1) BrainHQ; (2) BrainHQ&#x2009;+&#x2009;PASC-Cognitive Recovery; (3) BrainHQ&#x2009;+&#x2009;tDCS-active; (4) BrainHQ&#x2009;+&#x2009;tDCS-sham; and (5) Active Comparator. The interventions will occur for 10&#xa0;weeks. Assessments will be completed at baseline and at the end of intervention and will include cognitive testing and patient-reported surveys. All study activities can be delivered in Spanish and English.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This study is designed to test whether cognitive dysfunction symptoms can be alleviated by the use of pragmatic and established interventions with different mechanisms of action and with prior evidence of improving cognitive function in patients with neurocognitive disorder. If successful, results will provide beneficial treatments for PASC-related cognitive dysfunction.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT05965739. Registered on July 25, 2023.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Knopman</LastName><ForeName>David S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-6544-066X</Identifier><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, MN, USA. knopman@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Laskowitz</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Koltai</LastName><ForeName>Deborah C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charvet</LastName><ForeName>Leigh E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>New York University Grossman School of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Jacqueline H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federman</LastName><ForeName>Alex D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wisnivesky</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahncke</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Posit Science, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Vleet</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Posit Science, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong-Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Steen</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverstein</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lokhnygina</LastName><ForeName>Yuliya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feger</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Kanecia O</ForeName><Initials>KO</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05965739</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL156812</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1OT2HL156812-01 (OTA-20-011)</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="Y">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017322" MajorTopicYN="Y">Clinical Trials, Phase II as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065908" MajorTopicYN="N">Transcranial Direct Current Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Cognitive rehabilitation</Keyword><Keyword MajorTopicYN="N">Cognitive training</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Transcranial direct current stimulation</Keyword><Keyword MajorTopicYN="N">tDCS</Keyword></KeywordList><CoiStatement>DSK reports no conflicts with respect to the current work. Dr. Knopman serves on a Data Safety Monitoring Board for the Dominantly Inherited Alzheimer Network Treatment Unit study. He served on a Data Safety Monitoring Board for a tau therapeutic for Biogen (until 2021) but received no personal compensation. He was&#xa0;an investigator in clinical trials sponsored by Biogen, Lilly Pharmaceuticals, and the University of Southern California, a trial in frontotemporal degeneration with Alector. He has served as a consultant for Roche, Samus Therapeutics, Magellan Health, Biovie, and Alzeca Biosciences but receives no personal compensation. He receives funding from the NIH. JW has received an honorarium from Sanofi, PPD, Prospero, and Banook and research grants from Sanofi, Regeneron, Axella, and Arnold Consultants. LEC has consulted for Johnson &amp; Johnson, Neuroelectrics, and YBrain. HM and TVV are employees of and hold stock/stock options in Posit Science, the developers of BrainHQ.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38755688</ArticleId><ArticleId IdType="pmc">PMC11098733</ArticleId><ArticleId IdType="doi">10.1186/s13063-024-08156-z</ArticleId><ArticleId IdType="pii">10.1186/s13063-024-08156-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4:e2130645. doi: 10.1001/jamanetworkopen.2021.30645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.30645</ArticleId><ArticleId IdType="pmc">PMC8536953</ArticleId><ArticleId IdType="pubmed">34677597</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Lin JJ, Twumasi A, Goswami R, Carnavali F, Stone K, et al. Greater executive dysfunction in patients post-COVID-19 compared to those not infected. Brain Behav Immun. 2023;114:111&#x2013;117. doi: 10.1016/j.bbi.2023.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.08.014</ArticleId><ArticleId IdType="pubmed">37586567</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JH, Vannorsdall TD, Weisenbach SL. Evaluation of post-COVID-19 cognitive dysfunction: recommendations for researchers. JAMA Psychiat. 2023;80:1085&#x2013;1086. doi: 10.1001/jamapsychiatry.2023.2820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.2820</ArticleId><ArticleId IdType="pubmed">37585198</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;517. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrios H, Narciso S, Guerreiro M, Maroco J, Logsdon R, de Mendonca A. Quality of life in patients with mild cognitive impairment. Aging Ment Health. 2013;17:287&#x2013;292. doi: 10.1080/13607863.2012.747083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2012.747083</ArticleId><ArticleId IdType="pubmed">23215827</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787&#x2013;1794. doi: 10.1001/jama.2010.1553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1553</ArticleId><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan NJ, Wu Q, Rentz DM, Sperling RA, Marshall GA, Glymour MM. Loneliness, depression and cognitive function in older US adults. Int J Geriatr Psychiatry. 2017;32:564&#x2013;573. doi: 10.1002/gps.4495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4495</ArticleId><ArticleId IdType="pmc">PMC5102822</ArticleId><ArticleId IdType="pubmed">27162047</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Soung A, Sissoko C, Nordvig A, Canoll P, Mariani M, et al. COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis. Preprint Res Sq. 2021; rs.3.rs-1031824. Published 2021 Oct 29. 10.21203/rs.3.rs-1031824/v1.</Citation></Reference><Reference><Citation>Stefano GB, Buttiker P, Weissenberger S, Martin A, Ptacek R, Kream RM. Editorial: The pathogenesis of long-term neuropsychiatric COVID-19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. Med Sci Monit. 2021;27:e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AC, Devason AS, Umana IC, Cox TO, Dohnalova L, Litichevskiy L, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Even mild cases can cause &#x201c;COVID-19 fog&#x201d;. Columbia University Irving Medical Center. 2020. https://www.cuimc.columbia.edu/news/even-mild-cases-can-cause-covid-19-fog. Cited 2022 Dec 8.</Citation></Reference><Reference><Citation>Woo MS, Malsy J, Pottgen J, Seddiq Zai S, Ufer F, Hadjilaou A, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020 Nov 23;2(2):fcaa205. 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. Spirit 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e7586</ArticleId><ArticleId IdType="pmc">PMC3541470</ArticleId><ArticleId IdType="pubmed">23303884</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson GL, Marsh JM, Connors EJ, Terry DP. Normative reference values, reliability, and item-level symptom endorsement for the PROMIS&#xae; v2.0 cognitive function-short forms 4a, 6a and 8a. Arch Clin Neuropsychol. 2021;36:1341&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33454756</ArticleId></ArticleIdList></Reference><Reference><Citation>Case definitions for COVID-19 surveillance. Pan American Health Organization. 2022. https://www.paho.org/en/case-definitions-covid-19-surveillance. Cited Oct 15.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahncke HW, DeGutis J, Levin H, Newsome MR, Bell MD, Grills C, et al. A randomized clinical trial of plasticity-based cognitive training in mild traumatic brain injury. Brain. 2021;144:1994&#x2013;2008. doi: 10.1093/brain/awab202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab202</ArticleId><ArticleId IdType="pmc">PMC8370402</ArticleId><ArticleId IdType="pubmed">34312662</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah TM, Weinborn M, Verdile G, Sohrabi HR, Martins RN. Enhancing cognitive functioning in healthly older adults: A systematic review of the clinical significance of commercially available computerized cognitive training in preventing cognitive decline. Neuropsychol Rev. 2017;27:62&#x2013;80. doi: 10.1007/s11065-016-9338-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-016-9338-9</ArticleId><ArticleId IdType="pubmed">28092015</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GE, Housen P, Yaffe K, Ruff R, Kennison RF, Mahncke HW, et al. A cognitive training program based on principles of brain plasticity: Results from the improvement in memory with plasticity-based adaptive cognitive training (IMPACT) study. J Am Geriatr Soc. 2009;57:594&#x2013;603. doi: 10.1111/j.1532-5415.2008.02167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.02167.x</ArticleId><ArticleId IdType="pmc">PMC4169294</ArticleId><ArticleId IdType="pubmed">19220558</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebok GW, Ball K, Guey LT, Jones RN, Kim HY, King JW, et al. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc. 2014;62:16&#x2013;24. doi: 10.1111/jgs.12607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12607</ArticleId><ArticleId IdType="pmc">PMC4055506</ArticleId><ArticleId IdType="pubmed">24417410</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet LE, Yang J, Shaw MT, Sherman K, Haider L, Xu J, et al. Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial. PLoS ONE. 2017;12:e0177177. doi: 10.1371/journal.pone.0177177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177177</ArticleId><ArticleId IdType="pmc">PMC5426671</ArticleId><ArticleId IdType="pubmed">28493924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Heffner KL, Ren P, Tivarus ME, Brasch J, Chen DG, et al. Cognitive and neural effects of vision-based speed-of-processing training in older adults with amnestic mild cognitive impairment: A pilot study. J Am Geriatr Soc. 2016;64:1293&#x2013;1298. doi: 10.1111/jgs.14132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.14132</ArticleId><ArticleId IdType="pmc">PMC4916855</ArticleId><ArticleId IdType="pubmed">27321608</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner GR, Novakovic-Agopian T, Kornblith E, Adnan A, Madore M, Chen AJW, et al. Goal-oriented attention self-regulation (GOALS) training in older adults. Aging Ment Health. 2020;24:464&#x2013;473. doi: 10.1080/13607863.2018.1534080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2018.1534080</ArticleId><ArticleId IdType="pubmed">30724574</ArticleId></ArticleIdList></Reference><Reference><Citation>Novakovic-Agopian T, Posecion L, Kornblith E, Abrams G, McQuaid JR, Neylan TC, et al. Goal-oriented attention self-regulation training improves executive functioning in veterans with post-traumatic stress disorder and mild traumatic brain injury. J Neurotrauma. 2021;38:582&#x2013;592. doi: 10.1089/neu.2019.6806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6806</ArticleId><ArticleId IdType="pubmed">33019861</ArticleId></ArticleIdList></Reference><Reference><Citation>Loya F, Novakovic-Agopian T, Binder D, Rossi A, Rome S, Murphy M, et al. Long-term use and perceived benefits of goal-oriented attentional self-regulation training in chronic brain injury. Rehabil Res Pract. 2017;2017:8379347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318616</ArticleId><ArticleId IdType="pubmed">28265472</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B, Robertson IH, Clare L, Carter G, Hong J, Wilson BA, et al. Rehabilitation of executive functioning: An experimental-clinical validation of goal management training. J Int Neuropsychol Soc. 2000;6:299&#x2013;312. doi: 10.1017/S1355617700633052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617700633052</ArticleId><ArticleId IdType="pubmed">10824502</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet L. Cognitive functioning in MS improves with at-home online training paired with transcranial direct current stimulation (tdcs): Results from a sham-controlled randomized clinical trial. Brain Stimul. 2023;16(1):344&#x2013;344. doi: 10.1016/j.brs.2023.01.657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.657</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamenova V, Levine B. Effectiveness of goal management training(R) in improving executive functions: A meta-analysis. Neuropsychol Rehabil. 2019;29:1569&#x2013;1599. doi: 10.1080/09602011.2018.1438294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2018.1438294</ArticleId><ArticleId IdType="pubmed">29540124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavendish BA, Lima A, Bertola L, Charvet L, Bikson M, Brunoni AR, et al. Combination of transcranial direct current stimulation with online cognitive training improves symptoms of post-acute sequelae of COVID-19: A case series. Brain Stimul. 2022;15:1375&#x2013;1377. doi: 10.1016/j.brs.2022.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.008</ArticleId><ArticleId IdType="pmc">PMC9528061</ArticleId><ArticleId IdType="pubmed">36202328</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilam-Stock T, George A, Lustberg M, Wolintz R, Krupp LB, Charvet LE. Telehealth transcranial direct current stimulation for recovery from post-acute sequelae of SARS-CoV-2 (PASC) Brain Stimul. 2021;14:1520&#x2013;1522. doi: 10.1016/j.brs.2021.10.381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2021.10.381</ArticleId><ArticleId IdType="pmc">PMC8514329</ArticleId><ArticleId IdType="pubmed">34655835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilloni G, Vogel-Eyny A, Lustberg M, Best P, Malik M, Walton-Masters L, et al. Tolerability and feasibility of at-home remotely supervised transcranial direct current stimulation (RS-tDCS): Single-center evidence from 6,779 sessions. Brain Stimul. 2022;15:707&#x2013;716. doi: 10.1016/j.brs.2022.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.04.014</ArticleId><ArticleId IdType="pubmed">35470019</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias SET, Mungas D, Reed BR, Cahn-Weiner DA, Jagust WJ, Baynes K, et al. The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology. 2008;22(4):531&#x2013;544. doi: 10.1037/0894-4105.22.4.531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0894-4105.22.4.531</ArticleId><ArticleId IdType="pmc">PMC2877034</ArticleId><ArticleId IdType="pubmed">18590364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodakowski J, Golias KW, Reynolds CF, 3rd, Butters MA, Lopez OL, Dew MA, et al. Preventing disability in older adults with mild cognitive impairment: A strategy training intervention study. Contemp Clin Trials Commun. 2019;15:100368. doi: 10.1016/j.conctc.2019.100368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conctc.2019.100368</ArticleId><ArticleId IdType="pmc">PMC6512744</ArticleId><ArticleId IdType="pubmed">31111114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mace RA, Hopkins SW, Reynolds GO, Vranceanu AM. My healthy brain: Rationale and case report of a virtual group lifestyle program targeting modifiable risk factors for dementia. J Clin Psychol Med Settings. 2022;29:818&#x2013;830. doi: 10.1007/s10880-022-09843-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10880-022-09843-2</ArticleId><ArticleId IdType="pmc">PMC8788907</ArticleId><ArticleId IdType="pubmed">35079948</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe N, Ding X, Prasad G, Gillespie P, Finn DP, Todd S, et al. Alzheimer's disease assessments optimized for diagnostic accuracy and administration time. IEEE J Transl Eng Health Med. 2022;10:4900809. doi: 10.1109/JTEHM.2022.3164806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JTEHM.2022.3164806</ArticleId><ArticleId IdType="pmc">PMC9089816</ArticleId><ArticleId IdType="pubmed">35557505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The patient-reported outcomes measurement information system (PROMIS): Progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45:S3&#x2013;S11. doi: 10.1097/01.mlr.0000258615.42478.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000258615.42478.55</ArticleId><ArticleId IdType="pmc">PMC2829758</ArticleId><ArticleId IdType="pubmed">17443116</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilloni G, Woods AJ, Charvet L. No risk of skin lesion or burn with transcranial direct current stimulation (tdcs) using standardized protocols. Brain Stimul. 2021;14:511&#x2013;512. doi: 10.1016/j.brs.2021.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2021.03.006</ArticleId><ArticleId IdType="pubmed">33722658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikson M, Grossman P, Thomas C, Zannou AL, Jiang J, Adnan T, et al. Safety of transcranial direct current stimulation: Evidence based update 2016. Brain Stimul. 2016;9:641&#x2013;661. doi: 10.1016/j.brs.2016.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2016.06.004</ArticleId><ArticleId IdType="pmc">PMC5007190</ArticleId><ArticleId IdType="pubmed">27372845</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics (Basel). 2018;8(3):66. doi: 10.3390/diagnostics8030066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Novakovic-Agopian T, Kornblith E, Abrams G, Burciaga-Rosales J, Loya F, D'Esposito M, et al. Training in goal-oriented attention self-regulation improves executive functioning in veterans with chronic traumatic brain injury. J Neurotrauma. 2018;35:2784&#x2013;2795. doi: 10.1089/neu.2017.5529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5529</ArticleId><ArticleId IdType="pmc">PMC8104023</ArticleId><ArticleId IdType="pubmed">29717652</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y, Sato A, Shichi M, Sato A, Fujii K, Iwasa M, et al. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J Psychiatr. 2023;81:103438. doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>